# First Spark Ventures: Deep Tech Investment at Scale
First Spark Ventures is a California-based deep tech venture capital fund that deploys capital into breakthrough technologies designed to make the world healthier, safer, and more productive.[1][2] The firm operates from Menlo Park and focuses on early-stage companies—particularly those in Pre-seed, Seed, and Series A funding rounds—across three core verticals: Advanced Compute, Digital Biology & Biotech, and CyberPhysical Systems.[2] By targeting fundamental technological insights rather than incremental improvements, First Spark positions itself as a specialized investor in the infrastructure and scientific breakthroughs that will power the next generation of computing and life sciences innovation.
The firm's investment thesis reflects a conviction that as machine learning becomes ubiquitous, entirely new categories of opportunity emerge. First Spark seeks stellar teams with access to large markets and sustainable competitive advantages—the classic venture playbook applied rigorously to deep tech.[2] This approach has resulted in a portfolio spanning conversational AI, space technology, precision medicine, edge computing, and therapeutic platforms, each representing a different frontier of technological possibility.
Origin Story
First Spark Ventures was established with two funds opened in early 2022, signaling the firm's recent entry into the venture landscape.[4] The founding team includes Dr. Aaron Sisto and Dr. Haitao Zhu as Partners, alongside General Partners Danny Chen and Gal Treger, all based in Menlo Park.[4] The composition of the leadership team—anchored by individuals with "Dr." credentials—reflects the firm's deep commitment to science-driven investing and its ability to evaluate complex technical claims.
While specific founding narratives are limited in available information, the timing of First Spark's launch in early 2022 positioned it to capitalize on accelerating investment in deep tech following the pandemic-era surge in venture funding. The firm emerged during a period of heightened interest in autonomous systems, AI infrastructure, and biotech innovation—precisely the domains where First Spark concentrates its capital.
Core Differentiators
Specialized Deep Tech Focus
First Spark's differentiation lies in its explicit commitment to breakthrough technologies rather than consumer-facing software or traditional SaaS. This specialization requires technical depth from the investment team and a longer time horizon for returns—characteristics that distinguish the firm from generalist venture funds.[2]
Sector Concentration
The firm's three focus areas—Advanced Compute, Digital Biology & Biotech, and CyberPhysical Systems—represent adjacent but distinct domains where technological innovation can create durable moats. This concentration allows First Spark to develop genuine expertise and network effects within each vertical rather than spreading resources thinly across dozens of sectors.
Portfolio Quality Signals
First Spark's portfolio includes companies like Xona Space Systems (alternative GPS for autonomous systems), Inworld AI (conversational dialogue engines), and Vitara (therapeutic platform for premature infant lung development).[2] These investments signal the firm's ability to identify and back technically sophisticated founders solving hard problems. The presence of companies like Latent AI (edge AI inference) and Flower (federated learning infrastructure) further demonstrates focus on AI infrastructure—a critical layer of the technology stack.
Precision Medicine and Biotech Depth
The firm's biotech portfolio—including Curve Biosciences (precision medicine for chronic disease), Endometrics (endometriosis diagnosis), and Valitor (multi-valent biopolymer therapeutics)—suggests deep domain expertise in translating scientific insights into clinical applications.[2] This is not trivial; biotech investing requires understanding regulatory pathways, clinical trial design, and the long commercialization timelines that separate deep tech from faster-moving software ventures.
Role in the Broader Tech Landscape
First Spark Ventures operates at the intersection of several powerful macro trends. The first is the AI infrastructure wave—as large language models and machine learning become commoditized, the real value accrues to companies building the compute layers, inference optimization, and federated learning systems that make AI deployable at scale. First Spark's investments in Latent AI and Flower position the firm to capture returns from this infrastructure shift.
The second trend is autonomous systems and spatial computing. Xona Space Systems' alternative to GPS reflects a broader recognition that GPS is insufficient for the age of autonomous vehicles, drones, and robotics. As these systems proliferate, the underlying infrastructure—positioning, communication, computation—becomes critical. First Spark's CyberPhysical Systems focus directly addresses this market expansion.
The third is precision medicine and biotech innovation. The convergence of genomics, AI-driven drug discovery, and personalized therapeutics is creating new categories of biotech companies that can move faster and more efficiently than traditional pharma. First Spark's Digital Biology & Biotech portfolio reflects this shift toward data-driven, technology-enabled drug development.
Timing matters here. First Spark launched during a period when deep tech was gaining institutional credibility—no longer viewed as the domain of academic spinouts and government labs, but as a legitimate venture asset class. The firm's emergence in 2022 positioned it to deploy capital into companies that had already achieved technical proof-of-concept but still required venture-scale capital to reach commercialization.
Quick Take & Future Outlook
First Spark Ventures represents a disciplined bet on the thesis that the next decade of value creation will flow to companies solving hard technical problems in AI infrastructure, autonomous systems, and precision medicine. The firm's portfolio construction—concentrated, technically sophisticated, and geographically diverse—suggests a team comfortable with longer time horizons and higher technical risk than typical venture investors.
The path forward for First Spark will likely involve deepening expertise within its three core verticals while maintaining the flexibility to follow exceptional founders into adjacent domains. As AI infrastructure consolidates and autonomous systems move from prototype to production, the firm's early bets should generate meaningful returns—provided the underlying technologies achieve the performance and cost targets required for mass adoption.
What makes First Spark particularly interesting is not just *what* it invests in, but *how* it invests. By focusing on Pre-seed through Series A rounds, the firm positions itself as a foundational investor in companies still proving out core technology. This requires genuine technical judgment and a willingness to take on execution risk. In an era of mega-funds and late-stage capital abundance, First Spark's focus on early-stage deep tech represents a contrarian bet that the best returns come from backing scientists and engineers when their ideas are still unproven—but their potential is immense.